Pharmacogenomics in Geriatric Medicine addresses the unique genetic considerations in treating older populations. It explores how genetic variations affect drug metabolism, efficacy, and safety in elderly patients. The book emphasizes personalized treatment strategies to optimize pharmacotherapy and minimize adverse effects in geriatric care. Suitable for geriatricians and pharmacogenomic researchers, it advances precision medicine for aging populations.
Brandon Porter specializes in pharmacogenomics within geriatric dermatology, focusing on optimizing treatments for elderly patients based on their genetic profiles. His research explores how genetic variations influence responses to medications used in managing age-related skin conditions like rosacea and dermatitis. Brandon has published extensively on personalizing dermatological therapies for older adults through pharmacogenomic testing to enhance efficacy and minimize adverse effects. He also provides guidelines for clinicians to utilize pharmacogenomic insights in geriatric dermatological care, promoting safe and effective personalized treatments for elderly patients through genetic-informed approaches.